Bu sayfanın çevirisi deneyseldir ve geliştirilme aşamasındadır. imlerinizi bekliyoruz!
Uni-Bio Science Group Temettü
Temettü kriter kontrolleri 0/6
Uni-Bio Science Group does not have a record of paying a dividend.
Anahtar bilgiler
n/a
Temettü verimi
n/a
Ödeme oranı
| Sektör ortalama getirisi | 1.0% |
| Bir sonraki temettü ödeme tarihi | n/a |
| Eski temettü tarihi | n/a |
| Hisse başına temettü | n/a |
| Hisse başına kazanç | HK$0.016 |
| Temettü verim tahmini | n/a |
Son temettü güncellemeleri
Güncelleme yok
Recent updates
Uni-Bio Science Group Limited (HKG:690) Surges 35% Yet Its Low P/E Is No Reason For Excitement
Sep 13
Earnings Working Against Uni-Bio Science Group Limited's (HKG:690) Share Price Following 26% Dive
Jul 29Earnings Working Against Uni-Bio Science Group Limited's (HKG:690) Share Price Following 27% Dive
May 27Is Uni-Bio Science Group (HKG:690) Using Too Much Debt?
Apr 24Uni-Bio Science Group Limited (HKG:690) Held Back By Insufficient Growth Even After Shares Climb 28%
Jan 22Uni-Bio Science Group Limited's (HKG:690) Low P/S No Reason For Excitement
Oct 24Robust Earnings May Not Tell The Whole Story For Uni-Bio Science Group (HKG:690)
Apr 30We're Interested To See How Uni-Bio Science Group (HKG:690) Uses Its Cash Hoard To Grow
Nov 22Estimating The Fair Value Of Uni-Bio Science Group Limited (HKG:690)
Jan 05Companies Like Uni-Bio Science Group (HKG:690) Can Afford To Invest In Growth
Mar 01Uni-Bio Science Group (HKG:690) Share Prices Have Dropped 26% In The Last Five Years
Jan 05
We're Interested To See How Uni-Bio Science Group (HKG:690) Uses Its Cash Hoard To Grow
Nov 23Ödemelerde İstikrar ve Büyüme
Temettü verilerini getirme
İstikrarlı Temettü: Insufficient data to determine if 690's dividends per share have been stable in the past.
Büyüyen Temettü: Insufficient data to determine if 690's dividend payments have been increasing.
Piyasaya Karşı Temettü Getirisi
| Uni-Bio Science Group Piyasaya Karşı Temettü Getirisi |
|---|
| Segment | Temettü Verimi |
|---|---|
| Şirket (690) | n/a |
| Pazarın Alt %25'i (HK) | 3.1% |
| Pazarın En İyi %25'i (HK) | 7.9% |
| Sektör Ortalaması (Biotechs) | 1.0% |
| Analist tahmini (690) (3 yıla kadar) | n/a |
Önemli Temettü: Unable to evaluate 690's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
Yüksek Temettü: Unable to evaluate 690's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Hissedarlara Ödenen Kazanç
Kazanç Kapsamı: Insufficient data to calculate 690's payout ratio to determine if its dividend payments are covered by earnings.
Hissedarlara Nakit Ödeme
Nakit Akışı Kapsamı: Unable to calculate sustainability of dividends as 690 has not reported any payouts.